Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit Review1-Phenylbiguanide hydrochloride is a 5-HT3 receptor agonist.
M. Wt | 213.67 |
Formula | C8H11N5.HCl |
Storage | Store at RT |
CAS Number | 55-57-2 |
PubChem ID | 5932 |
InChI Key | FHUDRDSKZQDCBC-UHFFFAOYSA-N |
Smiles | Cl.NC(=N)NC(=N)NC1=CC=CC=C1 |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
References are publications that support the biological activity of the product.
Ireland and Tyer (1987) Pharmacological characterization of 5-hydroxytryptamine induced depolarization of the rat isolated vagus nerve. Br.J.Pharmacol. 90 229 PMID: 3814920
Keywords: 1-Phenylbiguanide hydrochloride, 1-Phenylbiguanide hydrochloride supplier, 5-HT3, agonists, Serotonin, Receptors, 0969, Tocris Bioscience
Citations are publications that use Tocris products.
Currently there are no citations for 1-Phenylbiguanide hydrochloride.
There are currently no reviews for this product. Be the first to review 1-Phenylbiguanide hydrochloride and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Written by Nicholas M. Barnes and John F. Neumaier, this review summarizes the various serotonin receptor subtypes and their importance in mediating the role of serotonin in numerous physiological and pharmacological processes. Compounds available from Tocris are listed.